Device type · LFR
Glucose Dehydrogenase, Glucose
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
LFR
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
822
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Glucose Dehydrogenase, Glucose
- Product code
- LFR
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1345
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for LFR
Latest FDA decisions
K152328 · Decided Sep 17, 2015 · 30 days after receipt
Device type: Glucose Dehydrogenase, Glucose (LFR) · Laboratory Medicine & Pathology
Reports received
822
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
794
97% of reports
Injury reports
28
3.4% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 11 | 0 | 0 | 0 |
| Jan 24 | 5 | 0 | 0 | 0 |
| Feb 24 | 10 | 0 | 0 | 0 |
| Mar 24 | 8 | 0 | 0 | 0 |
| Apr 24 | 11 | 0 | 0 | 0 |
| May 24 | 5 | 0 | 0 | 0 |
| Jun 24 | 6 | 0 | 0 | 0 |
| Jul 24 | 6 | 0 | 0 | 0 |
| Aug 24 | 14 | 0 | 0 | 0 |
| Sep 24 | 3 | 1 | 0 | 0 |
| Oct 24 | 6 | 1 | 0 | 0 |
| Nov 24 | 48 | 1 | 0 | 0 |
| Dec 24 | 42 | 4 | 0 | 0 |
| Jan 25 | 77 | 4 | 0 | 0 |
| Feb 25 | 64 | 3 | 0 | 0 |
| Mar 25 | 72 | 4 | 0 | 0 |
| Apr 25 | 75 | 1 | 0 | 0 |
| May 25 | 71 | 3 | 0 | 0 |
| Jun 25 | 57 | 1 | 0 | 0 |
| Jul 25 | 61 | 5 | 0 | 0 |
| Aug 25 | 49 | 5 | 0 | 0 |
| Sep 25 | 74 | 2 | 0 | 0 |
| Oct 25 | 62 | 1 | 0 | 0 |
| Nov 25 | 60 | 4 | 0 | 0 |
| Dec 25 | 77 | 4 | 0 | 0 |
| Jan 26 | 75 | 1 | 0 | 0 |
| Feb 26 | 53 | 1 | 0 | 0 |
| Mar 26 | 60 | 0 | 0 | 0 |
| Apr 26 | 47 | 2 | 0 | 0 |
| May 26 | 56 | 5 | 0 | 0 |
| Jun 26 | 60 | 0 | 0 | 0 |
| Jul 26 | 56 | 3 | 0 | 0 |
| Aug 26 | 76 | 1 | 0 | 0 |
| Sep 26 | 98 | 6 | 0 | 0 |
| Oct 26 | 76 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Imprecise or Erratic Results381
- High Test Results200
- Low Test Results81
- Non Reproducible Results64
- Incorrect, Inadequate or Imprecise Result or Readings38
- Unable to Obtain Readings18
- Computer Software Problem16
- Patient Data Problem11
- High Readings8
- Low Readings6
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions728
- Hypoglycemia36
- Hyperglycemia26
- Dizziness12
- Loss of consciousness12
- Diaphoresis8
- Fatigue8
- Elevated Ketones/ Diabetic Ketoacidosis5
- Headache4
- Shaking/Tremors4
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Accu-Chek Performa Test Strip, Blood Glucose Monitoring System, Model number 07299702001Open, Classified
Z-2352-2021 · Started Jul 28, 2021
Reason given: Test strip vials may open while inside sealed cartons during shipment. An open vial might expose the test strips to humidity, which might damage the strips and result in inaccurate results, potentially leading to inappropriate therapy decisions and adverse health consequences.
Cause as FDA categorized it: Package design/selection
- Accu-Chek SmartView Test Strip, Blood Glucose Monitoring System, Model numbers: 06337538001, 06337546001, 06337562001Open, Classified
Z-2353-2021 · Started Jul 28, 2021
Reason given: Test strip vials may open while inside sealed cartons during shipment. An open vial might expose the test strips to humidity, which might damage the strips and result in inaccurate results, potentially leading to inappropriate therapy decisions and adverse health consequences.
Cause as FDA categorized it: Package design/selection
Z-2185-2018 · Started May 7, 2018 · Posted by FDA May 9, 2018
Reason given: The recalling firm identified four US lots of test strips out of specification. Affected strips show increased potential for strip errors prior to applying blood, strips not detected once inserted, or biased results, which may not be detectable. In the case of a biased result, incorrect action could be taken by the...
Cause as FDA categorized it: Equipment maintenance
Z-2186-2018 · Started May 7, 2018 · Posted by FDA May 9, 2018
Reason given: The recalling firm has identified two lots of test strips that are out of specification. Affected test strips show an increased potential for: strip errors prior to applying a blood sample; strips not detected once inserted; or a biased result may occur, which may not be detectable. In the case of a biased result,...
Cause as FDA categorized it: Equipment maintenance
Z-2187-2018 · Started May 7, 2018 · Posted by FDA May 9, 2018
Reason given: The recalling firm has identified two lots of test strips that are out of specification. Affected test strips show an increased potential for: strip errors prior to applying a blood sample; strips not detected once inserted; or a biased result may occur, which may not be detectable. In the case of a biased result,...
Cause as FDA categorized it: Equipment maintenance
Roche Diagnostics Operations, Inc.
Z-1172-2016 · Started Feb 11, 2016 · Posted by FDA Mar 14, 2016
Reason given: Accu-Chek Inform II Base Unit might produce physical transmission errors in the form of data loss in the communication between the meter and the Data Management Systems (DMS). The issue can lead to the data loss or in the worst case to an erroneous assignment of the patient data (patient mismatch). The issue will only...
Cause as FDA categorized it: Software Design Change
Z-1359-2012 · Started Feb 21, 2012 · Posted by FDA Apr 2, 2012
Reason given: An error was discovered in the OneTouch IQ meter software so that the meter turns itself off when a user attempts to view results in the "Results Log" when the log has 256 or a multiple of 256 items to display.
Cause as FDA categorized it: Software design
Z-3268-2011 · Started Aug 12, 2011 · Posted by FDA Sep 19, 2011
Reason given: All 10- or 25- count glucose test strip vials, either loose vials or found in patient starter kits of Contour, Contour TS and Contour" USB blood glucose meters are being recalled a packaging issue which, under certain conditions, can cause some test strips packaged in some small-count vials to operate outside of US...
Cause as FDA categorized it: Packaging
Showing the 8 newest of 51 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.